PFS
GPCR icon

Prospera Financial Services’s Structure Therapeutics GPCR Stock Holding History

Prospera Financial Services’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+4,100
New +$181K ﹤0.01% 1360

Other funds holding GPCR

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

Prospera Financial Services's GPCR Position: Q2 2026 in Review

Prospera Financial Services opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 4,100 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #1360 among its holdings.

9 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Prospera Financial Services held 4,100 shares of Structure Therapeutics worth $220K as of Q2 2026.
  • Structure Therapeutics was a new Prospera Financial Services position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1360 holding.
  • 9 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.